BNP Paribas Financial Markets
ATXI

BNP Paribas Financial Markets’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

BNP Paribas Financial Markets’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– -$2 – 5067
2022
Q2 		– Hold
0
– – – 4079
2022
Q1 		– Hold
0
– – – 4137
2021
Q4 		– Hold
0
– – – 4163
2021
Q3 		– Hold
0
– – – 3952
2021
Q2 		– Sell
-1
Closed -$4.93K – 3989
2021
Q1 		$4.87K Hold
1
– – ﹤0.01% 3868
2020
Q4 		$6.25K Hold
1
– – ﹤0.01% 3953
2020
Q3 		$14.8K Buy
+1
New +$12.2K ﹤0.01% 3905
2020
Q2 		– Hold
0
– – – 4152

Other funds holding ATXI

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

BNP Paribas Financial Markets's ATXI Position: Q3 2022 in Review

BNP Paribas Financial Markets held its Avenue Therapeutics, Inc. Common Stock (ATXI) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5067.

BNP Paribas Financial Markets first reported a position in ATXI in Q3 2020 and has held it in 3 quarters since. The position peaked at $14.8K in Q3 2020. 10 funds tracked by Wall St. Rank hold ATXI as of Q3 2022.

  • BNP Paribas Financial Markets held 0 shares of Avenue Therapeutics, Inc. Common Stock worth $0 as of Q3 2022.
  • BNP Paribas Financial Markets left its Avenue Therapeutics, Inc. Common Stock share count unchanged in Q3 2022.
  • Avenue Therapeutics, Inc. Common Stock made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q3 2022, its #5067 holding.
  • BNP Paribas Financial Markets first reported a position in Avenue Therapeutics, Inc. Common Stock in Q3 2020 and has held it in 3 quarters since.
  • BNP Paribas Financial Markets's Avenue Therapeutics, Inc. Common Stock position peaked at $14.8K in Q3 2020.
  • 10 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q3 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.